acquisition
acquisition
Lonza Acquires Genentech’s $12B Biologics Site
📢 Lonza buys Genentech's CA biologics manufacturing site for $1.2B, boosting production capabilities for next-gen therapies. 🏭
AstraZeneca Buys Fusion Therapeutics for $2 Billion Revolutionizing Cancer Treatment
🔬 AstraZeneca is acquiring Fusion Therapeutics Inc for $2 billion upfront to transform cancer treatment with targeted therapies. 💰🌟
NanoString Acquired Slide Tags in Early Access Cellares Revolutionizes Cell Therapy Manufacturing!
👥 Authors: Alex Philippidis, Uduak Thomas, Jonathan D. Grinstein, PhD, and Corinna Singleman, PhD. 🗓️ Published on March 15, 2024. 💼 NanoString acquired, Slide Tags enter early access as Curio Trekker, and Cellares reveals cell therapy manufacturing platform.
AstraZeneca Acquires Amolyt Pharma for $105bn!
📢 AstraZeneca to acquire Amolyt Pharma for $1.05bn 💼💰 with $800m upfront and potential milestone payments of $250m. Amazing news for biotech in France and Europe!
Novo Holdings Acquires Catalent for $165B Sells Sites for $11B: Tapping into Obesity and Diabetes Drug Market
📢 Novo Holdings acquires Catalent for $16.5B 💰 and sells 3 sites to Novo Nordisk for $11B 💼 to meet demand for obesity and diabetes drugs.
Novo Holdings Invests $165bn in CDMO Catalent Fueling Biotech Growth
🔍 Novo Holdings buys CDMO Catalent for $16.5bn, aiming to support its expansion in the CDMO market. 🏢💼📈
Alcami Boosts Storage Services with Pacific Pharma Acquisition!
📢 Alcami acquires Pacific Pharma Group, boosting storage services. 💼 Expansion in pharmaceutical storage, logistics, and temperature-controlled distribution. 🌡️ Strengthening global biotech presence. 💪🌍
Game-Changing Respiratory Breakthrough: GSK’s $14bn Aiolos Bio Acquisition!
📢 GSK breathes new life into its respiratory pipeline with $1.4bn Aiolos Bio acquisition, reinforcing commitment to patients worldwide. 😷💊🌍
BMS Expands Oncology Portfolio with $41bn RayzeBio Acquisition
💼 Bristol Myers Squibb (BMS) acquires RayzeBio for $4.1bn, expanding its oncology portfolio with targeted radiopharmaceuticals. ⚕️🎯
AstraZeneca’s $12bn Chinese Biotech Power Move
🌍💊 AstraZeneca boosts cell therapy projects by acquiring Gracell Biotechnologies for $1.2bn to fight cancer and autoimmune diseases. 🦠🚀 Expected to close Q1 2024.
